MHRA warning on aspirin treatment

Aspirin is not licensed for primary prevention of vascular disease, the MHRA has warned in its latest drug safety update.

In the UK, aspirin is only licensed for secondary prevention of cardiovascular disease

A number of recent studies have shown that the risks of aspirin outweigh the benefits in primary prevention, lending support to the licensed indications.

Research presented at the European Society of Cardiology congress in Barcelona, Spain, last month found that routine aspirin use failed to cut the number of non-fatal coronary events or strokes compared with placebo.

But despite the lack of evidence, a number of GPs still continue to prescribe aspirin for primary prevention.

The MHRA advises health professionals that if aspirin is used in primary prevention, the balance of benefits and risks should be considered for each individual, particularly the presence of risk factors for vascular disease and the risk of GI bleeding.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

London GP personally calling at-risk patients to boost COVID-19 vaccine uptake

London GP personally calling at-risk patients to boost COVID-19 vaccine uptake

London GP Dr Farzana Hussain is personally telephoning scores of patients who have...

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Almost half of people who experienced potential cancer symptoms in the first wave...

GP premises need major investment to let PCNs recruit, warns BMA

GP premises need major investment to let PCNs recruit, warns BMA

Primary care networks (PCNs) are struggling to make use of hundreds of millions of...

NHS unveils £4.2m fund to tackle vaccine inequality

NHS unveils £4.2m fund to tackle vaccine inequality

CCGs with low uptake of COVID-19 vaccine in ethnic minority, marginalised or deprived...

150,000 more people with learning disabilities prioritised for COVID-19 vaccine

150,000 more people with learning disabilities prioritised for COVID-19 vaccine

Around 150,000 more people will be prioritised for COVID-19 vaccination after the...